Sign In
Buy TLRY
$4.54
+0.340 (+8.10%)
At Close: Jul 31, 2026
Tilray Surges 10%: Rescheduling Momentum Builds as Traders Await Official Confirmation
09:32am, Thursday, 23'rd Apr 2026
Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday.
Tilray stock price soars as we predicted: now what?
09:08am, Thursday, 23'rd Apr 2026
The Tilray stock price has risen in the past few days, a trend that accelerated this week. It jumped to a high of $8, up by over 30% from its lowest level this year.
Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling
08:53am, Thursday, 23'rd Apr 2026
Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients
BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer
07:00am, Thursday, 23'rd Apr 2026
COLUMBUS, Ohio, April 23, 2026 (GLOBE NEWSWIRE) -- BrewDog USA by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), today unveiled its lineup of headliner products and bold innovation bets for spri
Tilray Brands (TLRY) Price Forecast: Cannabis Rescheduling Fuels Recovery
04:59pm, Wednesday, 22'nd Apr 2026
Tilray stock shows early reversal signals as U.S. cannabis rescheduling momentum builds, with a breakout and technical strength pointing toward a potential recovery continuation.
Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substance
02:49pm, Wednesday, 22'nd Apr 2026
The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive order to reclassify the substance in December.
Tilray Stock Jumps As Trump Administration Eyes Marijuana Reclassification: Report
12:56pm, Wednesday, 22'nd Apr 2026
Shares of cannabis giant Tilray Brands Inc (NASDAQ:TLRY) are trading higher Wednesday afternoon following breaking news of a potential major regulatory shift. Here's what investors need to know.
1 Wall Street Analyst Says Tilray Stock Could Jump Over 40%. Should You Believe It?
04:20am, Wednesday, 22'nd Apr 2026
Roth Capital's Bill Kirk predicts that Tilray's shares could soar by more than 40% over the next 12 months. His bullish outlook stems from three encouraging signs with Tilray's business.
Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care
09:56am, Monday, 20'th Apr 2026
NEW YORK and LEAMINGTON, Ontario, April 20, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company a
The cannabis stock has lost around 96% of its value over the past five years.
Tilray Brands, Inc. $TLRY Shares Sold by Freestone Capital Holdings LLC
04:07am, Friday, 17'th Apr 2026
Freestone Capital Holdings LLC trimmed its position in Tilray Brands, Inc. (NASDAQ: TLRY) by 90.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commi
3 Marijuana Stocks That Could Help You Make A Profit In Cannabis
12:40pm, Wednesday, 15'th Apr 2026
Marijuana stock investors are still in a position where volatility and speculation control the outcome. Especially with all the laws and regulatory changes that have transformed the cannabis industry.
Here's why the Tilray Brands stock may surge soon despite major risks
08:53am, Wednesday, 15'th Apr 2026
Tilray Brands stock price has moved sideways in the past few weeks as momentum in the cannabis industry waned. It was trading at $6.90, down by over 70% from its highest level last year.
Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership
07:40am, Wednesday, 15'th Apr 2026
Tilray Advances UK Healthcare Platform with Lyphe Acquisition, Positions BrewDog for Strong Growth, and Prepares for U.S. Rescheduling and Medical Cannabis Opportunity Tilray Advances UK Healthcare Pl
Tilray's revenue rose by 11% last quarter, but its growth has been volatile over the years. Its beverage sales have more than doubled in four years, largely due to acquisitions.
